🌐 WorldLive

Seamless Therapeutics Announces Global Research Collaboration With Lilly To Develop Programmable Recombinase-Based Therapeutics For Hearing Loss

(MENAFN - GlobeNewsWire - Nasdaq) -- Collaboration will advance a next generation gene editing approach by combining Seamless' expertise in developing highly precise and efficient recombinases ...

📖 Lire l'article complet

Cet article provient de menafn

Lire sur le site source →
← Retour à l'accueil Plus d'articles Science